Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Symposium on Signalling Pathways in Cancer 2018

Cyclin-dependent kinases (CDKs)

Start date: 23 Mar 2018
End date: 24 Mar 2018
Location: Barcelona, Spain

The 6^th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), focused on Cyclin-dependent kinases (CDKs).

Create your own personalised agenda and browse the complete scientific programme by day, topic, cancer type and track with the ESMO events app.

It was the next important step in a strategic collaboration between basic scientists and translational and clinical researchers. The aim was to foster close cooperation among academics, clinical and industry researchers in a highly interactive hands-on professional environment.

The Scientific Committee was composed of some of the world’s leading experts in modern cancer medicine. They worked together to ensure you learn and discuss the most advanced approaches known to us today.